ARTICLE | Clinical News
Hemosol Inc. preclinical data
February 4, 2002 8:00 AM UTC
HML said that treatment with HRC-102 protected red blood cells against peroxyl-mediated damage in vitro. Results were presented at the American Society of Transplant Surgeons meeting in Miami. ...